KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · IEX Real-Time Price · USD
10.35
-0.86 (-7.67%)
At close: Apr 24, 2024, 4:00 PM
10.25
-0.10 (-0.97%)
After-hours: Apr 24, 2024, 7:13 PM EDT

KalVista Pharmaceuticals Income Statement

Millions USD. Fiscal year is May - Apr.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
00012.6916.138.391.52.1300.03
Upgrade
Revenue Growth (YoY)
----21.31%92.13%458.11%-29.49%---93.01%
Upgrade
Gross Profit
00012.6916.138.391.52.1300.03
Upgrade
Selling, General & Admin
30.626.4516.6413.0310.938.8611.182.651.613.41
Upgrade
Research & Development
80.2870.1741.2940.1935.0218.2412.6714.668.298.29
Upgrade
Operating Expenses
110.8796.6157.9253.2245.9527.123.8417.319.8911.71
Upgrade
Operating Income
-110.87-96.61-57.92-40.53-29.82-18.71-22.34-15.18-9.89-11.68
Upgrade
Interest Expense / Income
0000000001.08
Upgrade
Other Expense / Income
-17.96-14.27-11.68-11.29-9.13-2.9-3.74-3.75-2.670.6
Upgrade
Pretax Income
-92.91-82.34-46.24-29.24-20.69-15.81-18.6-11.44-7.23-13.36
Upgrade
Income Tax
000-0.120.1200000
Upgrade
Net Income
-92.91-82.34-46.24-29.12-20.82-15.81-18.6-11.44-7.23-13.36
Upgrade
Shares Outstanding (Basic)
2824191815105100
Upgrade
Shares Outstanding (Diluted)
2824191815105100
Upgrade
Shares Change
13.97%28.17%7.58%17.69%46.11%122.13%685.86%124.52%501.93%44.79%
Upgrade
EPS (Basic)
-3.33-3.36-2.42-1.64-1.38-1.53-4.47-26.17-34.94-305.34
Upgrade
EPS (Diluted)
-3.33-3.36-2.42-1.64-1.38-1.53-4.47-26.17-34.94-305.34
Upgrade
Free Cash Flow
-76.46-79.07-30.25-45.04-37.459.13-23.8-13.17-6.49-11.41
Upgrade
Free Cash Flow Per Share
-2.74-3.23-1.58-2.54-2.480.89-5.12-22.27-24.66-260.83
Upgrade
Gross Margin
---100.00%100.00%100.00%100.00%100.00%-100.00%
Upgrade
Operating Margin
----319.41%-184.91%-222.84%-1485.31%-711.72%--40265.52%
Upgrade
Profit Margin
----229.44%-129.08%-188.29%-1236.90%-536.15%--46065.52%
Upgrade
Free Cash Flow Margin
----354.89%-232.19%108.78%-1582.18%-617.30%--39351.72%
Upgrade
EBITDA
-92.11-81.6-45.59-28.72-20.31-15.63-18.56-11.4-7.19-12.22
Upgrade
EBITDA Margin
----226.28%-125.96%-186.14%-1234.24%-534.60%--42148.28%
Upgrade
Depreciation & Amortization
0.80.740.650.530.380.180.040.030.040.05
Upgrade
EBIT
-92.91-82.34-46.24-29.24-20.69-15.81-18.6-11.44-7.23-12.28
Upgrade
EBIT Margin
----230.42%-128.31%-188.29%-1236.90%-536.15%--42334.48%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).